Literature DB >> 1353258

Studies on the origin of rat hippocampal dihydroxyphenylacetic acid using microdialysis.

A Vahabzadeh1, M Fillenz.   

Abstract

With a dialysis probe implanted in the rat ventral hippocampus we have monitored effects on noradrenaline (NA) and dihydroxyphenylacetic acid (DOPAC) of the infusion through the dialysis probe of drugs acting at dopaminergic and noradrenergic presynaptic autoreceptors; clonidine and idazoxan produced changes in the extracellular concentration of both NA and DOPAC, whereas LY171555 and sulpiride had no effect on NA but produced changes in the concentration of DOPAC. The combined effect of clonidine and LY171555 on DOPAC was additive. Hippocampal DOPAC is therefore derived from both the noradrenergic and the dopaminergic projection to the hippocampus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1353258     DOI: 10.1016/0304-3940(92)90645-n

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Alpha 2-autoreceptors and alpha 2-heteroreceptors modulating tyrosine and tryptophan hydroxylase activity in the rat brain in vivo: an investigation into the alpha 2-adrenoceptor subtypes.

Authors:  S Esteban; J Lladó; J A García-Sevilla
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-03       Impact factor: 3.000

2.  Altered in vivo catecholamine release in the hypothalamic paraventricular nucleus of the aged rat.

Authors:  J A Hastings; J M Pavia; M J Morris
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-01       Impact factor: 3.000

3.  Changes in extracellular levels of dopamine metabolites in somatosensory cortex after peripheral denervation.

Authors:  M E Jiménez-Capdeville; T A Reader; E Molina-Holgado; R W Dykes
Journal:  Neurochem Res       Date:  1996-01       Impact factor: 3.996

4.  Modulation of hippocampal dopamine metabolism and hippocampal-dependent cognitive function by catechol-O-methyltransferase inhibition.

Authors:  L M Laatikainen; T Sharp; D M Bannerman; P J Harrison; E M Tunbridge
Journal:  J Psychopharmacol       Date:  2012-07-19       Impact factor: 4.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.